Healthcare Services

Night Blindness Treatment Market Outlook 2026–2030 Exploring New Business Opportunities

April 3, 2026April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Night Blindness Treatment Market Between 2026 And 2030?

The night blindness treatment market has experienced significant expansion in recent years. Its value is expected to rise from $4.2 billion in 2025 to $4.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.3%. The market’s historical development was primarily influenced by factors such as the high prevalence of malnutrition, limited access to eye care services, growing awareness of vision disorders, an increasing geriatric population, and advancements in ophthalmic diagnostics.

The night blindness treatment market size is anticipated to experience robust expansion in the coming years. It is projected to reach $5.66 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.1%. This projected growth is driven by increased investment in eye health programs, a rising demand for personalized treatments, the broader application of gene therapy, improvements in healthcare infrastructure, and more advantageous reimbursement policies. Significant trends during this forecast period include a growing prevalence of vitamin A deficiency, wider adoption of early diagnosis techniques, an increase in minimally invasive eye surgeries, the expanding use of nutritional and preventive therapies, and enhanced access to vision care in emerging economies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18413&type=smp

What Drivers Are Influencing The Night Blindness Treatment Market?

An upward trend in cataract cases is anticipated to drive expansion in the night blindness treatment market moving ahead. Cataracts are defined as a condition characterized by the clouding of the eye’s natural lens, resulting in diminished vision. Factors such as elevated exposure to solar ultraviolet (UV) light, smoking, and inadequate dietary habits play a role in cataract formation. This condition diminishes the eye’s capacity to differentiate light and dark contrasts, a function vital for nocturnal vision. Consequently, this diminished contrast sensitivity impedes navigation and object identification in dimly lit settings. As an illustration, data from May 2024, provided by the Office for Health Improvement & Disparities, a UK-based government department, revealed that hospital admissions for cataract surgery in England reached over 516,000 in the financial year ending 2023, which corresponds to 4,679 per 100,000 people. This represented a notable increase from the preceding year’s figure of 3,803 per 100,000. Hence, the growing incidence of cataracts is a key factor propelling the night blindness treatment market.

Which Market Segments Are Examined In The Night Blindness Treatment Market Study?

The night blindness treatment market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Other Treatments

2) By Diagnosis: Blood Tests, Color Vision Testing, Pupil Light Reflex, Refraction, Retinal Exam, Electroretinogram (ERG), Other Diagnoses

3) By Symptom: Eye Pain, Cloudy Vision, Halos, Light Sensitivity, Distance Vision Problem, Other Symptoms

4) By End User: Clinic, Hospital, Other End Users

Subsegments:

1) By Medication: Vitamin A Supplements, Retinoid Therapy, Beta-Carotene Supplements, Anti-Glaucoma Medications

2) By Surgery: Cataract Surgery, Retinal Surgery, Corneal Transplantation, LASIK Surgery

3) By Other Treatments: Light Therapy, Gene Therapy, Low Vision Aids And Assistive Devices, Nutritional Therapy

What Trends Are Affecting The Expansion Of The Night Blindness Treatment Market?

Leading companies in the night blindness treatment market are actively developing innovative genetic therapies to address the root genetic mutations responsible, thereby enhancing treatment efficacy and improving patient outcomes. Genetic therapies work by targeting and repairing specific genetic mutations that impact retinal function, potentially restoring vision for individuals with inherited retinal disorders such as retinitis pigmentosa. For instance, in August 2023, HuidaGene Therapeutics., a US-based clinical-stage biotechnology company, unveiled HG004, a gene therapy created to treat inherited retinal diseases like Leber’s congenital amaurosis. Preclinical studies have indicated this therapy’s superiority over existing treatments, with its objective being to restore retinal function and alleviate night blindness and other conditions linked to RPE65-induced impairments.

Who Are The Primary Competitors In The Night Blindness Treatment Market?

Major companies operating in the night blindness treatment market are Johnson & Johnson Private Limited, Bayer AG, Abbott Laboratories, Novartis AG, Regeneron Pharmaceuticals Inc, Bausch Health Companies Inc, Cipla Inc, Nature’s Way, Garden of Life, Apellis Pharmaceuticals Inc, Solgar, Acucela Inc, Swanson Health Products, Astellas Pharma Inc, F. Hoffmann‑La Roche Ltd, Applied Genetic Technologies Corp, MeiraGTx Holdings plc, GenSight Biologics, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Opthea Limited, Oxurion NV, EyePoint Pharmaceuticals Inc, Ocuphire Pharma Inc.

Read the full night blindness treatment market report here:

https://www.thebusinessresearchcompany.com/report/night-blindness-treatment-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Night Blindness Treatment Market?

North America was the largest region in the night blindness treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the night blindness treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Night Blindness Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18413&type=smp

Browse Through More Reports Similar to the Global Night Blindness Treatment Market 2026, By The Business Research Company

Alpers Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/alpers-disease-treatment-global-market-report

Rare Inflammatory Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Rare Neurological Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795